An observational study in Respiratory Disease, sponsored by Data Collection Analysis Business Management. Status unknown at 1 site in United States. Open to participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-23.
Sponsored by Data Collection Analysis Business Management · Observational
Among 71 studies in Respiration Disorders with a site in United States — 15 open to participants now, 19 under way, 1 of them phase 3. Respiration Disorders · United States.
Among the 71 studies in Respiration Disorders with a site in United States, this one is the 15th largest by planned enrollment of the 23 observational ones that give a count, is one of 3 that started in 2017, is one of 23 observational ones, and was the 26th registered.
359 studies on the registry are indexed under Respiration Disorders; 64 are open to participants now.
Browse Respiration Disorders studies →15 of the 71 studies in Respiration Disorders with a site in United States are open now. Recruiting first, the newest first:
Windward Bio · Sites in United States, Argentina
Ages 40–80
Quantec Ltd · Sites in United States
Ages 60+ · Healthy volunteers
Geisinger Clinic · Sites in United States
Ages 65–100
University of Florida · Sites in United States
Ages 1 hrs–3 days
University of Louisville · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 45 Respiration Disorders studies recruiting now, 27 (60%) set no upper age limit and 13 (29%) stop at 75 or younger; 15 take children under 18; 21 take healthy volunteers.
This study: 18 Years to 64 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
71 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 10 · Phase 3 5 · Phase 4 3
First in 1997; this study’s year is marked. 3 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 200 is below the median of 250 across 134 observational studies indexed under Respiration Disorders.
Median enrollment 86 across the 48 interventional studies, 450 across the 23 observational. Of the 44 that completed or were terminated, 15 (34%) have results posted.
This tab as a report to print or save as PDF → With an account.
32 of 71 have an industry lead sponsor. The 10 most frequent:
Data Collection Analysis Business Management is the lead sponsor of 9 studies on the registry; none are open to participants now.
Data Collection Analysis Business Management has 1 study filed under Respiration Disorders — fewer than ten, so there is no comparison to draw.
5 of the studies in Respiration Disorders with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07217197Thomas Jefferson UniversityRespiratory Monitoring System That Detects & Predicts OIRD | 2026-11-30 |
| NCT06495021Geisinger ClinicHow OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care. | 2026-12-31 |
| NCT05527652University of MichiganSelf-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia | 2027-05 |
| NCT04179981VA Office of Research and DevelopmentImpact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome) | 2027-09-30 |
| NCT03319446BioFire Diagnostics, LLCCollection of Anonymized Samples | 2027-10 |
Add all 5 to your calendar (.ics) → With an account.
Among the 71 studies in Respiration Disorders with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Reviewing providers' current standard operating procedure on Respiratory Pathogen testing
The general design of this study is collecting data and reviewing Principal Investigators' Standard Operating Procedures on Respiratory Pathogen testing and changes made to their specific SOP.
Current standard operating procedures for providers
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Must be a Medical Practitioner
Exclusion Criteria:
lab testing for respiratory pathogens
Provider Structures and Processes
Plan of Care Changes due to Respiratory Pathogen testing. Provider based observational survey system on the health and well-being of patients and populations
Time frame: 36 months
Started Oct 2017 (actual). Primary completion is estimated for Oct 2020, 36 months after the start.
Of 60 non-industry observational studies under Respiration Disorders, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 60. This study's planned 36 months is above that.
Counting every sponsor, half of 75 studies reached it within 26 months; a quarter within 10 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Data Collection Analysis Business Management